SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]
SEC Accession No. 0001178913-22-004417
Filing Date
2022-12-27
Accepted
2022-12-27 07:00:19
Documents
5
Period of Report
2022-12-27

Document Format Files

Seq Description Document Type Size
1 6-K/A zk2228920.htm 6-K/A 66669
2 image00001.jpg GRAPHIC 1597
3 image00002.jpg GRAPHIC 1876
4 image00003.jpg GRAPHIC 5683
5 image00004.jpg GRAPHIC 4972
  Complete submission text file 0001178913-22-004417.txt   87567
Mailing Address 21 HA'ARBA'A STREET TEL AVIV L3 64739
Business Address 21 HA'ARBA'A STREET TEL AVIV L3 64739 972-3-541-3131
RedHill Biopharma Ltd. (Filer) CIK: 0001553846 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3
Type: 6-K/A | Act: 34 | File No.: 001-35773 | Film No.: 221486787
SIC: 2834 Pharmaceutical Preparations